[1] In phase 3 trials, orforglipron produced 12.4% weight loss (27.3 lbs) at 72 weeks less than injectable tirzepatide (20%) but comparable to oral semaglutide
First: weight loss drugs in this class require indefinite use to maintain results
Upper right abdominal pain, fever, or yellowing of skin/eyes : These may indicate gallbladder disease, which occurs at higher rates in patients taking GLP-1 medications
After working with many patients on GLP-1 medications, Stanford and Cardel gave their 10 best tips for avoiding nausea
(Remember: If you dont have insurance or youre not covered, you can still access GLP-1 medication and at a fraction of the list price when you pay cash on Ro.) 5
GLP-1 Info Patients Injectable Compounded Semaglutide Pursuant to the FDAs removal of Injectable Semaglutide Brands from the FDA Drug Shortage List, we are not purchasing or dispensing this product